Integer Holdings Corporation (NYSE:ITGR – Get Free Report) has earned an average rating of “Hold” from the ten ratings firms that are covering the firm, Marketbeat.com reports. Six research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 12-month target price among brokers that have issued ratings on the stock in the last year is $102.00.
ITGR has been the subject of a number of research reports. Citigroup upped their target price on shares of Integer from $75.00 to $92.00 and gave the stock a “neutral” rating in a report on Friday, February 20th. Weiss Ratings raised shares of Integer from a “sell (d+)” rating to a “hold (c-)” rating in a report on Tuesday, February 24th. Truist Financial upped their price objective on shares of Integer from $95.00 to $97.00 and gave the company a “buy” rating in a report on Friday, February 20th. Wall Street Zen lowered shares of Integer from a “buy” rating to a “hold” rating in a report on Sunday, January 25th. Finally, Raymond James Financial reissued an “outperform” rating and issued a $101.00 price objective on shares of Integer in a report on Monday, February 23rd.
View Our Latest Stock Analysis on ITGR
Insider Activity
Institutional Investors Weigh In On Integer
Hedge funds have recently modified their holdings of the company. Salomon & Ludwin LLC purchased a new stake in shares of Integer in the third quarter valued at about $26,000. Global Retirement Partners LLC grew its holdings in shares of Integer by 293.8% in the third quarter. Global Retirement Partners LLC now owns 319 shares of the medical equipment provider’s stock valued at $33,000 after purchasing an additional 238 shares during the period. TD Private Client Wealth LLC grew its holdings in shares of Integer by 1,037.5% in the fourth quarter. TD Private Client Wealth LLC now owns 455 shares of the medical equipment provider’s stock valued at $36,000 after purchasing an additional 415 shares during the period. Parkside Financial Bank & Trust grew its holdings in shares of Integer by 135.5% in the fourth quarter. Parkside Financial Bank & Trust now owns 464 shares of the medical equipment provider’s stock valued at $36,000 after purchasing an additional 267 shares during the period. Finally, Arax Advisory Partners grew its holdings in shares of Integer by 2,489.5% in the fourth quarter. Arax Advisory Partners now owns 492 shares of the medical equipment provider’s stock valued at $39,000 after purchasing an additional 473 shares during the period. Hedge funds and other institutional investors own 99.29% of the company’s stock.
Integer Price Performance
Integer stock opened at $90.37 on Thursday. Integer has a 52-week low of $62.00 and a 52-week high of $127.56. The firm has a market capitalization of $3.08 billion, a price-to-earnings ratio of 31.49, a PEG ratio of 1.49 and a beta of 0.71. The company has a fifty day simple moving average of $86.06 and a 200-day simple moving average of $82.73. The company has a quick ratio of 2.23, a current ratio of 3.32 and a debt-to-equity ratio of 0.69.
Integer (NYSE:ITGR – Get Free Report) last released its earnings results on Thursday, February 19th. The medical equipment provider reported $1.76 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.70 by $0.06. Integer had a net margin of 5.55% and a return on equity of 13.26%. The business had revenue of $472.06 million during the quarter, compared to analyst estimates of $462.73 million. During the same quarter in the prior year, the firm earned $1.43 earnings per share. The company’s revenue for the quarter was up 5.0% compared to the same quarter last year. Integer has set its FY 2026 guidance at 6.290-6.780 EPS. On average, equities analysts anticipate that Integer will post 6.01 EPS for the current fiscal year.
About Integer
Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.
Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.
Further Reading
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.
